10x Genomics, Inc. Class A Common Stock (NASDAQ: TXG) last traded at $75.19, down 6.77% on the session. The quote above updates while this page is open; the figures below are drawn from 10x Genomics, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
10x Genomics, Inc. Class A Common Stock trades on NASDAQ under the ticker TXG. Its market capitalisation is $9.60 billion.
Valuation measures for 10x Genomics, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.60B |
|---|---|
| Enterprise value | $9.30B |
| Price / sales | 15.56 |
| Price / book | 11.63 |
| Beta | 2.23 |
Trailing-twelve-month figures tagged in 10x Genomics, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $616.91M |
|---|---|
| Net income (TTM) | -$75.13M |
| EPS (TTM) | -$0.590 |
| Gross margin | 70.03% |
| Operating margin | -14.33% |
| Return on equity | -9.10% |
| Cash | $502.51M |
Range and volume for TXG over the past 52 weeks.
| 52-week high | $102.81 |
|---|---|
| 52-week low | $11.16 |
| Volume | 4.08M |
| Average volume | 3.32M |
| Previous close | $80.65 |
Invest a chosen dollar amount in 10x Genomics, Inc. Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TXG.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.